Skip to content

ICAAC: Nevirapine still present in breastmilk two weeks after last dose

ICAAC: Achillion reveals potential for once weekly dosing of nucleoside analogue

South African study finds many patients die waiting for treatment after enrolment into antiretroviral rollout programme

ICAAC: No added benefit from adding AZT to nevirapine to prevent MTCT

UK Government to be sued over lack of PEP policy for sexual exposure to HIV

ICAAC: Nevirapine and rifampicin can be safely used together

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

New study looks at impact of AIDS on South Africa

Advocacy groups demand equal HIV treatment access for injecting drug users